Ngā hua rapu - Chelsea Cates‐Gatto
- E whakaatu ana i te 1 - 4 hua o te 4
-
1
Comparison of the effects of the GABAB receptor positive modulator BHF177 and the GABAB receptor agonist baclofen on anxiety-like behavior, learning, and memory in mice mā Xia Li, Victoria B. Risbrough, Chelsea Cates‐Gatto, Katarzyna Kaczanowska, M. G. Finn, Amanda J. Roberts, Athina Markou
I whakaputaina 2013Artigo -
2
Increased IL-6 expression in astrocytes is associated with emotionality, alterations in central amygdala GABAergic transmission, and excitability during alcohol withdrawal mā Amanda J. Roberts, Sophia Khom, Michal Bajo, Roman Vlkolinský, Ilham Polis, Chelsea Cates‐Gatto, Marisa Roberto, Donna L. Gruol
I whakaputaina 2019Artigo -
3
Enhanced activity of Alzheimer disease-associated variant of protein kinase Cα drives cognitive decline in a mouse model mā Gema Lordén, Jacob M. Wozniak, Kim Doré, Lara E. Dozier, Chelsea Cates‐Gatto, Gentry N. Patrick, David J. Gonzalez, Amanda J. Roberts, Rudolph E. Tanzi, Alexandra C. Newton
I whakaputaina 2022Artigo -
4
GIRK3 gates activation of the mesolimbic dopaminergic pathway by ethanol mā Melissa A. Herman, Harpreet Sidhu, David G. Stouffer, Max Kreifeldt, David Le, Chelsea Cates‐Gatto, Michaelanne B. Munoz, Amanda J. Roberts, Loren H. Parsons, Marisa Roberto, Kevin Wickman, Paul A. Slesinger, Candice Contet
I whakaputaina 2015Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Neuroscience
Psychology
Biochemistry
Biology
Central nervous system
Chemistry
Internal medicine
Medicine
Psychiatry
Agonist
Alzheimer's disease
Amnesia
Amygdala
Anxiety
Anxiolytic
Astrocyte
Baclofen
Cell biology
Central nucleus of the amygdala
Cognition
Cognitive decline
Conditioned place preference
Dementia
Dendritic spine
Disease
Dopamine
Dopaminergic
Dopaminergic pathways
Druggability
Elevated plus maze